Exabis Library
Welcome to the e-CCO Library!
P433: Sex-based differences in response to tumor necrosis factor inhibitor induction therapy for ulcerative colitis: a pooled analysis of individual patient-level clinical trials data
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P434 Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from Eneida Registry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P434: Close rectal versus total mesorectal excision in patients with inflammatory bowel disease undergoing proctocolectomy or completion proctectomy
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P434: Factors associated with medical and psycosocioeconomic changes in IBD during the COVID-19 pandemic and post-pandemic period
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P434: Joint Inflammatory Bowel Disease–Obstetric clinics: outcomes in 95 pregnancies at a tertiary centre over a 3-year period
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P434: Remission induction in corticosteroid naive children and adolescents with active ulcerative colitis by adsorptive leucocytapheresis after failure of first-line medications: Results from routine clinical practice
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P434: Surgery management of Crohn's disease in children: our experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P434: The PROPER study: interim analysis of a Pan-European real-world study of SB5 adalimumab biosimilar after transition from reference adalimumab in patients with Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P434: Upadacitinib improved fatigue and health-related quality of life in patients with moderately to severely active Crohn's disease: Results from induction and maintenance phase 3 trials
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P435 Real-world clinical outcomes after elective discontinuation of first-use biologics in IBD patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P435: Effectiveness of therapeutic drug monitoring of infliximab and adalimumab in inflammatory bowel disease patients. Systematic review and meta-analysis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P435: High rate of vitamin deficiencies in patients after total proctocolectomy and pouch surgery- results from a prospective cohort
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P435: Liver injury associated with anti-tumour necrosis factor therapy in paediatric irritable bowel disease patients
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P435: Rapidity of symptomatic and inflammatory biomarker improvements following upadacitinib induction treatment: data from the U-ACHIEVE study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P435: Real-world comparison of effectiveness between ustekinumab and a second anti-TNF agent in patients with symptomatic stenosing Crohn's disease after failure of a first anti-TNF agent: results of the USTEKNOSIS study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P435: The impact of perianal fistula in Crohn’s disease on quality of life: results of a patient survey conducted in Europe
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P435: The mean corpuscular volume flow – prognostic value for inflammatory bowel disease under thiopurine treatment
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P436 Evaluation of targeted vitamin D supplementation regimen in postoperative patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P436: Adalimumab dose escalation is effective and well tolerated in Crohn’s disease patients with secondary loss of response to adalimumab
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P436: Darvadstrocel treatment outcomes in Crohn’s disease patients with complex perianal fistulas: the role of TNFi co-treatment in ADMIRE CD
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM